Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).



Status:Recruiting
Conditions:Lung Cancer, Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 127
Updated:11/29/2018
Start Date:June 1, 2017
End Date:September 24, 2021
Contact:AstraZeneca Clinical Study Information Center
Email:information.center@astrazeneca.com
Phone:1-877-240-9479

Use our guide to learn which trials are right for you!

A Phase III, Randomized, Multi-Center, Open-Label, Comparative Global Study to Determine the Efficacy of Durvalumab or Durvalumab and Tremelimumab in Combination With Platinum-Based Chemotherapy for First-Line Treatment in Patients With Metastatic Non Small-Cell Lung Cancer (NSCLC) (POSEIDON)

This is a randomized, open-label, multi-center, global, Phase III study to determine the
efficacy and safety of durvalumab + tremelimumab combination therapy + Standard of care (SoC)
chemotherapy or durvalumab monotherapy + SoC chemotherapy versus SoC chemotherapy alone as
first line treatment in patients with metastatic non small-cell lung cancer (NSCLC) with
tumors that lack activating epidermal growth factor receptor (EGFR) mutations and anaplastic
lymphoma kinase (ALK) fusions.

Adult patients with a histologically or cytologically documented metastatic NSCLC, with
tumors that lack activating EGFR mutations and ALK fusions, are eligible for enrollment.
Patients will be randomized in a 1:1:1 ratio to receive treatment with durvalumab +
tremelimumab combination therapy + SoC chemotherapy, durvalumab monotherapy + SoC
chemotherapy, or SoC chemotherapy alone. Tumor evaluation scans will be performed until
objective disease progression as efficacy assessment. All patients will be followed for
survival until the end of the study. An independent data monitoring committee (IDMC) composed
of independent experts will be convened to confirm the safety and tolerability of the
proposed dose and schedule.

Inclusion Criteria:

For inclusion in the study, patients should fulfill the following criteria:

1. Aged at least 18 years.

2. Histologically or cytologically documented Stage IV NSCLC.

3. Confirmed tumor PD-L1 status prior to randomization.

4. Patients must have tumors that lack activating EGFR mutations and ALK fusions.

5. No prior chemotherapy or any other systemic therapy for metastatic NSCLC.

6. World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance
status of 0 or 1.

7. No prior exposure to immunemediated therapy, excluding therapeutic anticancer
vaccines.

Exclusion Criteria:

Patients should not enter the study if any of the following exclusion criteria are
fulfilled:

1. Mixed small-cell lung cancer and NSCLC histology, sarcomatoid variant.

2. Active or prior documented autoimmune or inflammatory disorders.

3. Brain metastases or spinal cord compression unless the patient's condition is stable
and off steroids.

4. Active infection including tuberculosis, hepatitis B, hepatitis C, or human
immunodeficiency virus.
We found this trial at
27
sites
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
?
mi
from
Bakersfield, CA
Click here to add this to my saved trials
?
mi
from
Barretos,
Click here to add this to my saved trials
?
mi
from
Canton, OH
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Edina, MN
Click here to add this to my saved trials
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Louisville, KY
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
?
mi
from
Richmond, VA
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Petersburg, Florida 33713
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
San Luis Obispo, California 93405
?
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
?
mi
from
White Plains, NY
Click here to add this to my saved trials